Lanhai Medical Investment Co., Ltd. Logo

Lanhai Medical Investment Co., Ltd.

600896.SS

(1.2)
Stock Price

1,12 CNY

-12.33% ROA

-13.53% ROE

-4.09x PER

Market Cap.

0,00 CNY

12.97% DER

0% Yield

-240.39% NPM

Lanhai Medical Investment Co., Ltd. Stock Analysis

Lanhai Medical Investment Co., Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Lanhai Medical Investment Co., Ltd. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.59x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a minimal amount of debt (13%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Graham Number

Based on the Graham number, this company's stock price appears to be lower than its intrinsic value, signaling a potentially favorable investment choice.

4 ROE

Negative ROE (-13.53%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (-12.33%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (1), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Lanhai Medical Investment Co., Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Lanhai Medical Investment Co., Ltd. Technical Stock Analysis
# Analysis Recommendation

Lanhai Medical Investment Co., Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Lanhai Medical Investment Co., Ltd. Revenue
Year Revenue Growth
1993 106.615.288
1994 153.206.565 30.41%
1995 141.335.110 -8.4%
1996 148.330.042 4.72%
1997 215.643.538 31.22%
1998 314.435.254 31.42%
1999 307.079.844 -2.4%
2000 434.151.889 29.27%
2001 473.512.975 8.31%
2002 449.836.882 -5.26%
2003 514.412.140 12.55%
2004 579.987.099 11.31%
2005 734.882.091 21.08%
2006 605.363.039 -21.4%
2007 959.263.657 36.89%
2008 1.171.998.117 18.15%
2009 842.167.770 -39.16%
2010 1.249.021.097 32.57%
2011 1.203.569.275 -3.78%
2012 1.017.380.281 -18.3%
2013 1.042.877.929 2.44%
2014 1.044.028.212 0.11%
2015 952.245.055 -9.64%
2016 854.224.310 -11.47%
2017 44.111.204 -1836.52%
2018 53.050.882 16.85%
2019 31.118.218 -70.48%
2020 74.393.626 58.17%
2021 118.502.383 37.22%
2022 96.953.928 -22.23%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Lanhai Medical Investment Co., Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
1993 0
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 22.752.930 100%
2017 8.020.769 -183.68%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Lanhai Medical Investment Co., Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
1993 4.952.496
1994 10.712.245 53.77%
1995 10.491.253 -2.11%
1996 11.884.872 11.73%
1997 13.773.745 13.71%
1998 17.009.814 19.02%
1999 9.358.362 -81.76%
2000 27.155.188 65.54%
2001 39.249.084 30.81%
2002 25.930.633 -51.36%
2003 32.124.305 19.28%
2004 31.600.784 -1.66%
2005 33.275.902 5.03%
2006 21.104.838 -57.67%
2007 54.962.627 61.6%
2008 51.393.879 -6.94%
2009 52.489.227 2.09%
2010 15.312.660 -242.78%
2011 18.454.377 17.02%
2012 13.626.002 -35.44%
2013 14.731.319 7.5%
2014 12.148.042 -21.26%
2015 14.459.532 15.99%
2016 31.333.984 53.85%
2017 22.837.271 -37.21%
2018 24.329.524 6.13%
2019 13.874.893 -75.35%
2020 20.618.765 32.71%
2021 16.250.745 -26.88%
2022 76.959.428 78.88%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Lanhai Medical Investment Co., Ltd. EBITDA
Year EBITDA Growth
1993 41.975.383
1994 45.795.758 8.34%
1995 32.785.675 -39.68%
1996 35.976.221 8.87%
1997 65.347.535 44.95%
1998 173.356.373 62.3%
1999 132.859.961 -30.48%
2000 139.472.090 4.74%
2001 115.057.993 -21.22%
2002 119.774.542 3.94%
2003 129.257.647 7.34%
2004 105.722.525 -22.26%
2005 177.574.064 40.46%
2006 195.998.192 9.4%
2007 368.538.447 46.82%
2008 253.532.356 -45.36%
2009 147.433.650 -71.96%
2010 220.773.821 33.22%
2011 222.886.187 0.95%
2012 -115.272.044 293.36%
2013 327.309.295 135.22%
2014 182.915.797 -78.94%
2015 397.813.459 54.02%
2016 -202.822.986 296.14%
2017 -606.553.350 66.56%
2018 202.910.239 398.93%
2019 -118.757.286 270.86%
2020 116.264.078 202.14%
2021 -218.481.104 153.21%
2022 -166.961.925 -30.86%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Lanhai Medical Investment Co., Ltd. Gross Profit
Year Gross Profit Growth
1993 49.922.602
1994 59.257.333 15.75%
1995 48.576.251 -21.99%
1996 39.179.105 -23.99%
1997 80.458.600 51.31%
1998 133.434.859 39.7%
1999 83.595.791 -59.62%
2000 100.401.364 16.74%
2001 73.801.112 -36.04%
2002 73.263.178 -0.73%
2003 109.149.377 32.88%
2004 108.859.598 -0.27%
2005 181.197.611 39.92%
2006 157.847.276 -14.79%
2007 324.842.228 51.41%
2008 348.575.867 6.81%
2009 64.531.178 -440.17%
2010 118.797.689 45.68%
2011 75.979.490 -56.35%
2012 -43.577.556 274.35%
2013 -27.565.603 -58.09%
2014 40.536.528 168%
2015 48.288.535 16.05%
2016 73.977.773 34.73%
2017 38.615.021 -91.58%
2018 -53.617.769 172.02%
2019 -81.758.269 34.42%
2020 -48.148.342 -69.8%
2021 -34.161.988 -40.94%
2022 -81.863.860 58.27%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Lanhai Medical Investment Co., Ltd. Net Profit
Year Net Profit Growth
1993 37.391.182
1994 37.122.472 -0.72%
1995 23.244.116 -59.71%
1996 32.772.700 29.07%
1997 56.629.687 42.13%
1998 114.338.726 50.47%
1999 64.423.197 -77.48%
2000 67.449.421 4.49%
2001 48.268.832 -39.74%
2002 55.187.576 12.54%
2003 49.315.207 -11.91%
2004 33.551.733 -46.98%
2005 111.526.973 69.92%
2006 145.389.151 23.29%
2007 263.990.549 44.93%
2008 135.821.344 -94.37%
2009 15.395.844 -782.19%
2010 25.318.977 39.19%
2011 12.709.396 -99.21%
2012 -373.413.498 103.4%
2013 19.734.876 1992.15%
2014 -194.126.649 110.17%
2015 24.140.349 904.16%
2016 -459.366.932 105.26%
2017 -692.999.972 33.71%
2018 114.433.375 705.59%
2019 -175.167.051 165.33%
2020 61.279.242 385.85%
2021 -284.871.648 121.51%
2022 -195.551.400 -45.68%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Lanhai Medical Investment Co., Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1993 0
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 -1 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 -1 0%
2017 -1 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Lanhai Medical Investment Co., Ltd. Free Cashflow
Year Free Cashflow Growth
1998 -4.534.157
1999 1.772.454 355.81%
2000 19.225.665 90.78%
2001 39.737.409 51.62%
2002 25.387.742 -56.52%
2003 11.780.537 -115.51%
2004 95.752.432 87.7%
2005 162.086.713 40.93%
2006 41.411.659 -291.4%
2007 -618.411.949 106.7%
2008 -494.546.432 -25.05%
2009 24.167.428 2146.33%
2010 -913.958.470 102.64%
2011 -928.782.437 1.6%
2012 -1.048.912.634 11.45%
2013 -217.705.957 -381.8%
2014 -91.701.473 -137.41%
2015 160.442.413 157.16%
2016 -299.612.613 153.55%
2017 -627.633.197 52.26%
2018 -169.086.982 -271.19%
2019 -143.398.481 -17.91%
2020 -202.525.231 29.19%
2021 -515.341.354 60.7%
2022 -2.632.616 -19475.26%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Lanhai Medical Investment Co., Ltd. Operating Cashflow
Year Operating Cashflow Growth
1998 124.299.197
1999 83.024.400 -49.71%
2000 132.710.048 37.44%
2001 71.925.936 -84.51%
2002 108.698.032 33.83%
2003 60.800.849 -78.78%
2004 99.705.304 39.02%
2005 165.330.944 39.69%
2006 54.355.422 -204.17%
2007 300.166.964 81.89%
2008 247.389.028 -21.33%
2009 124.585.841 -98.57%
2010 37.324.299 -233.79%
2011 88.291.889 57.73%
2012 -15.732.576 661.2%
2013 80.037.263 119.66%
2014 64.473.179 -24.14%
2015 189.831.388 66.04%
2016 -166.646.908 213.91%
2017 -272.791.791 38.91%
2018 -70.705.486 -285.81%
2019 -73.575.739 3.9%
2020 -34.587.772 -112.72%
2021 -126.772.373 72.72%
2022 -1 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Lanhai Medical Investment Co., Ltd. Capital Expenditure
Year Capital Expenditure Growth
1998 128.833.355
1999 81.251.946 -58.56%
2000 113.484.382 28.4%
2001 32.188.526 -252.56%
2002 83.310.290 61.36%
2003 49.020.312 -69.95%
2004 3.952.873 -1140.12%
2005 3.244.232 -21.84%
2006 12.943.763 74.94%
2007 918.578.912 98.59%
2008 741.935.460 -23.81%
2009 100.418.413 -638.84%
2010 951.282.769 89.44%
2011 1.017.074.326 6.47%
2012 1.033.180.058 1.56%
2013 297.743.220 -247%
2014 156.174.652 -90.65%
2015 29.388.975 -431.41%
2016 132.965.706 77.9%
2017 354.841.406 62.53%
2018 98.381.496 -260.68%
2019 69.822.742 -40.9%
2020 167.937.459 58.42%
2021 388.568.981 56.78%
2022 2.632.615 -14659.81%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Lanhai Medical Investment Co., Ltd. Equity
Year Equity Growth
2002 816.372.112
2003 865.687.319 5.7%
2004 880.202.099 1.65%
2005 973.204.670 9.56%
2006 1.070.445.315 9.08%
2007 1.369.551.374 21.84%
2008 1.439.056.484 4.83%
2009 2.970.983.930 51.56%
2010 2.387.367.519 -24.45%
2011 2.029.661.779 -17.62%
2012 1.685.972.595 -20.39%
2013 1.590.251.869 -6.02%
2014 2.048.581.304 22.37%
2015 1.488.226.281 -37.65%
2016 2.416.560.034 38.42%
2017 1.673.556.977 -44.4%
2018 1.773.990.662 5.66%
2019 1.592.430.784 -11.4%
2020 2.247.352.872 29.14%
2021 1.962.873.985 -14.49%
2022 1.917.206.699 -2.38%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Lanhai Medical Investment Co., Ltd. Assets
Year Assets Growth
2002 1.054.286.779
2003 1.072.350.683 1.68%
2004 1.084.930.551 1.16%
2005 1.171.488.147 7.39%
2006 1.469.524.272 20.28%
2007 2.475.114.856 40.63%
2008 2.388.568.839 -3.62%
2009 4.968.989.031 51.93%
2010 4.868.561.963 -2.06%
2011 4.907.631.637 0.8%
2012 5.707.375.424 14.01%
2013 5.593.279.636 -2.04%
2014 6.467.701.442 13.52%
2015 5.516.378.652 -17.25%
2016 4.367.037.077 -26.32%
2017 4.283.417.151 -1.95%
2018 2.297.726.606 -86.42%
2019 2.271.021.009 -1.18%
2020 2.887.976.514 21.36%
2021 2.682.120.680 -7.68%
2022 2.637.662.632 -1.69%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Lanhai Medical Investment Co., Ltd. Liabilities
Year Liabilities Growth
2002 147.156.749
2003 118.380.686 -24.31%
2004 116.398.333 -1.7%
2005 106.382.892 -9.41%
2006 317.431.182 66.49%
2007 794.109.346 60.03%
2008 690.566.257 -14.99%
2009 1.667.612.583 58.59%
2010 2.130.999.631 21.75%
2011 2.522.566.457 15.52%
2012 3.654.403.414 30.97%
2013 3.641.632.964 -0.35%
2014 4.009.764.063 9.18%
2015 3.565.212.648 -12.47%
2016 1.664.528.667 -114.19%
2017 2.310.006.148 27.94%
2018 487.549.463 -373.8%
2019 645.077.759 24.42%
2020 631.699.866 -2.12%
2021 713.581.553 11.47%
2022 718.011.355 0.62%

Lanhai Medical Investment Co., Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.11
Net Income per Share
-0.27
Price to Earning Ratio
-4.09x
Price To Sales Ratio
0x
POCF Ratio
-9.19
PFCF Ratio
0
Price to Book Ratio
0.59
EV to Sales
-1.54
EV Over EBITDA
0.84
EV to Operating CashFlow
1.44
EV to FreeCashFlow
0.35
Earnings Yield
-0.24
FreeCashFlow Yield
0
Market Cap
0,00 Bil.
Enterprise Value
-0,18 Bil.
Graham Number
3.41
Graham NetNet
-0.26

Income Statement Metrics

Net Income per Share
-0.27
Income Quality
0.45
ROE
-0.14
Return On Assets
-0.11
Return On Capital Employed
-0.13
Net Income per EBT
1
EBT Per Ebit
1.04
Ebit per Revenue
-2.31
Effective Tax Rate
-0

Margins

Sales, General, & Administrative to Revenue
0.14
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
-0.29
Operating Profit Margin
-2.31
Pretax Profit Margin
-2.4
Net Profit Margin
-2.4

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
-0.05
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.12
Free CashFlow per Share
-0.5
Capex to Operating CashFlow
3.07
Capex to Revenue
-3.28
Capex to Depreciation
-6.99
Return on Invested Capital
-0.12
Return on Tangible Assets
-0.12
Days Sales Outstanding
-0
Days Payables Outstanding
634.93
Days of Inventory on Hand
18.6
Receivables Turnover
-9.9407003805286E+14
Payables Turnover
0.57
Inventory Turnover
19.62
Capex per Share
-0.37

Balance Sheet

Cash per Share
0,42
Book Value per Share
1,89
Tangible Book Value per Share
1.53
Shareholders Equity per Share
1.89
Interest Debt per Share
0.25
Debt to Equity
0.13
Debt to Assets
0.09
Net Debt to EBITDA
0.84
Current Ratio
2.14
Tangible Asset Value
1,60 Bil.
Net Current Asset Value
0,36 Bil.
Invested Capital
0.13
Working Capital
0,57 Bil.
Intangibles to Total Assets
0.14
Average Receivables
0,00 Bil.
Average Payables
0,22 Bil.
Average Inventory
7020087
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Lanhai Medical Investment Co., Ltd. Dividends
Year Dividends Growth
1997 0
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2014 0 0%

Lanhai Medical Investment Co., Ltd. Profile

About Lanhai Medical Investment Co., Ltd.

Lanhai Medical Investment Co., Ltd. provides medical and health services. The company operates rehabilitation hospitals. It also offers financial insurance services; and industrial investment services. The company was formerly known as China Shipping Haisheng Co., Ltd. and changed its name to Lanhai Medical Investment Co., Ltd. in November 2016. Lanhai Medical Investment Co., Ltd. was founded in 1989 and is based in Shanghai, China.

CEO
Mr. Xiang Du
Employee
264
Address
No. 201 Century Avenue
Shanghai, 200120

Lanhai Medical Investment Co., Ltd. Executives & BODs

Lanhai Medical Investment Co., Ltd. Executives & BODs
# Name Age

Lanhai Medical Investment Co., Ltd. Competitors